APP and Alzheimer disease: Conversely, an increased proportion of Aβ42 promotes parenchymal amyloid deposition as seen in familial AD cases, where gene mutations shift APP processing toward aggregation-prone Aβ42, resulting in primarily parenchymal amyloid pathology [9, 23, 24].